The Motley Fool

British American Tobacco plc Beats Imperial Tobacco Group PLC

british american tobacco / imperial tobaccoSmoking is becoming socially more unacceptable in the developed world, yet the FTSE 100‘s two listed tobacco giants continue to ship almost unimaginable volumes of the stuff every year.

In its last full year, British American Tobacco (LSE: BATS) (NYSE: BTI.US) sold 676 billion cigarettes, while rival Imperial Tobacco (LSE: IMT) shifted a total stick equivalent of 317 billion. That’s nearly one trillion cigarettes, from just those two companies!

Claim your FREE copy of The Motley Fool’s Bear Market Survival Guide.

Global stock markets may be reeling from the coronavirus, but you don’t have to face this down market alone. Help yourself to a FREE copy of The Motley Fool’s Bear Market Survival Guide and discover the five steps you can take right now to try and bolster your portfolio… including how you can aim to turn today’s market uncertainty to your advantage. Click here to claim your FREE copy now!

What might seem worrying is that those volumes represented a 2.7% fall for British American and and a 7% fall for Imperial. And it’s part of a trend — a year previously, British American’s volumes were down 1.7% while Imperial’s dropped 2.7%. But what about the financials? Here’s a quick snapshot of the latest situation:

  British American
Imperial Tobacco
EPS growth 2013 +5% +5%
P/E 2013 14.9 10.9
Dividend Yield 2013 4.4% 5.1%
Dividend Cover 2013 1.53x 1.81x
EPS growth 2014*
-2% -3%
P/E 2014 16.5 12.3
Dividend Yield 2014 4.3% 5.2%
Dividend Cover 2014 1.45x 1.59x
EPS growth 2015* +8% +4%
P/E 2015 15.3 11.8
Dividend Yield 2015 4.6% 5.6%
Dividend Cover 2015 1.45x 1.51x

* forecast

Profits looking good

Both are keeping their revenues and profits rising, despite the slowdown in volumes — in fact, the 5% EPS growth they both enjoyed in 2013 comes on the back of strongly rising profit trends. (There’s a small drop in earnings for this year forecast, but a 9% fall in the pound against the dollar over 12 months is going to hit any company reporting in sterling).

The trick, which the two companies are pulling off, is to move away from attempts to sell ever more low-margin products to the poorer developing world, and to focus their marketing efforts on the prestigious upmarket brands that many of today’s newly wealthy want to be seen with.

How long that will work against a growing health-led aversion to the filthy stuff is anybody’s guess — but I’d wager we’ll see another good decade or two of rising (or at least stable) profits from this pair.

Which is better?

Looking at the figures above, Imperial is offering better dividend yields with better cover, from shares on a lower P/E. So isn’t it the obvious choice?

Not necessarily, because it comes largely down to size and marketing clout. British American has a market cap of £65bn versus Imperial’s £24bn, and is producing nearly three times the pre-tax profit with signifiantly better margins — British American’s product mix is already better geared towards the higher-profitability end of the market.

And British American’s volumes are falling more slowly — 2.7% in 2013 against 7% for Imperial, and Imperial’s Growth Brand volumes actually fell by 2% that year. And more than half of Imperial’s sales in 2013 came from Western Europe, where social unacceptability is perhaps growing most strongly.

Biggest fish

In a market that’s becoming increasingly tough, my money (if I’d invest it in tobacco, which I actually wouldn’t) would be on the bigger and better diversified British American Tobacco.

If you seek shares with great dividends and growth prospects for the future, you'll find more ideas in "The Fool’s Five Shares To Retire On" report. They're nicely diversified across the FTSE sectors too, so you'll get a nicely balanced selection.

The report is completely free, so click here to get your copy today!

Alan Oscroft has no position in any shares mentioned. The Motley Fool has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.